HSA — authorised 7 April 1986
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇸🇬 Clindamycin 2-Palmitate in Singapore
HSA authorised Clindamycin 2-Palmitate on 7 April 1986
Marketing authorisation
Clindamycin 2-Palmitate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Singapore
Frequently asked questions
Is Clindamycin 2-Palmitate approved in Singapore?
Yes. HSA authorised it on 7 April 1986.
Who is the marketing authorisation holder for Clindamycin 2-Palmitate in Singapore?
PHARMACIA AND UPJOHN holds the Singaporean marketing authorisation.